Taka-Diastase
Order now: dominika@ksiazkiwnauce.pl
Diastovaricin I |
|||
GL2663-500UG | Glentham Life Sciences | 500 ug | 206.4 EUR |
Diastovaricin I |
|||
GL2663-5MG | Glentham Life Sciences | 5 mg | 661.2 EUR |
Diastovaricin I |
|||
GL2663-1 | Glentham Life Sciences | 1 | 204.5 EUR |
Diastovaricin I |
|||
GL2663-5 | Glentham Life Sciences | 5 | 516.3 EUR |
Diastovaricin I |
|||
GL2663-500 | Glentham Life Sciences | 500 | 145.5 EUR |
Lysinoalanine · 2 HCl (diastereomeric mixture: LL + LD) |
|||
F-1195.0050 | Bachem | 50.0mg | 370.8 EUR |
Description: Sum Formula: C9H19N3O4·2HCl; CAS# [4418-81-9] |
|||
Lysinoalanine · 2 HCl (diastereomeric mixture: LL + LD) |
|||
F-1195.0250 | Bachem | 250.0mg | 1371.6 EUR |
Description: Sum Formula: C9H19N3O4·2HCl; CAS# [4418-81-9] |
|||
3-Methyl-1,2-cyclopentanediol mixture of diastereomers 95% |
|||
M15290 | Pfaltz & Bauer | 1G | 202.48 EUR |
2-Di-1-ASP |
|||
HY-135009 | MedChemExpress | 10mM/1mL | 135.6 EUR |
4-Di-1-ASP |
|||
70006-1 | Biotium | EA | 121 EUR |
4-Di-2-ASP |
|||
GW1929-1 | Glentham Life Sciences | 1 | 251.3 EUR |
4-Di-2-ASP |
|||
GW1929-5 | Glentham Life Sciences | 5 | 837.5 EUR |
2-Di-1-ASP |
|||
T18883-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 2-Di-1-ASP |
|||
2-Di-1-ASP |
|||
T18883-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 2-Di-1-ASP |
|||
2-Di-1-ASP |
|||
T18883-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 2-Di-1-ASP |
|||
2-Di-1-ASP |
|||
T18883-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 2-Di-1-ASP |
|||
2-Di-1-ASP |
|||
T18883-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 2-Di-1-ASP |
|||
Pasireotide diaspartate |
|||
329636 | MedKoo Biosciences | 1.0mg | 250 EUR |
Pasireotide diaspartate |
|||
T28298-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Pasireotide diaspartate |
|||
Pasireotide diaspartate |
|||
T28298-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Pasireotide diaspartate |
|||
Pasireotide diaspartate |
|||
T28298-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Pasireotide diaspartate |
|||
Pasireotide diaspartate |
|||
T28298-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Pasireotide diaspartate |
|||
Pasireotide diaspartate |
|||
T28298-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Pasireotide diaspartate |
|||
4-(4-(Dimethylamino)-styryl)-N-methylpyridinium iodide (4-Di-1-ASP) |
|||
70006 | Biotium | 500MG | 163.2 EUR |
Description: Minimum order quantity: 1 unit of 500MG |
|||
Tak-438 |
|||
abx188897-1g | Abbexa | 1 g | 1813.2 EUR |
TAK-901 |
|||
B1945-25 | Biovision | each | 1005.6 EUR |
TAK-901 |
|||
B1945-5 | Biovision | each | 301.2 EUR |
TAK-700 |
|||
B2209-5 | Biovision | each | 248.4 EUR |
TAK-593 |
|||
B3268-10 | ApexBio | 10 mg | 602.4 EUR |
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system. |
|||
TAK-593 |
|||
B3268-100 | ApexBio | 100 mg | 2666.4 EUR |
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system. |
|||
TAK-593 |
|||
B3268-5 | ApexBio | 5 mg | 385.2 EUR |
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system. |
|||
TAK-593 |
|||
B3268-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 417.6 EUR |
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system. |
|||
TAK-593 |
|||
B3268-50 | ApexBio | 50 mg | 1752 EUR |
Description: TAK-593 is a highly potent inhibitor of VEGFR2 with IC50 value of 0.95nM [1].TAK-593 is an imidazo [1, 2-b] pyridazine derivative. It is found to inhibit VEGFR2 with a highly potent effect in the non-RI assay using the AlphaScreen system. |
|||
TAK-715 |
|||
B1701-25 | Biovision | each | 757.2 EUR |
TAK-715 |
|||
B1701-5 | Biovision | each | 235.2 EUR |
TAK-733 |
|||
B1621-10 | ApexBio | 10 mg | 373.2 EUR |
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1]. |
|||
TAK-733 |
|||
B1621-5 | ApexBio | 5 mg | 226.8 EUR |
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1]. |
|||
TAK-733 |
|||
B1621-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 234 EUR |
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1]. |
|||
TAK-733 |
|||
B1621-50 | ApexBio | 50 mg | 1005.6 EUR |
Description: TAK-733 is a potent, ATP-noncompetitive and selective inhibitor of MEK allosteric site with the IC50 value of 3.2nM [1]. |
|||
TAK960 |
|||
B5860-10 | ApexBio | 10 mg | 303.6 EUR |
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes. |
|||
TAK960 |
|||
B5860-5 | ApexBio | 5 mg | 226.8 EUR |
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes. |
|||
TAK960 |
|||
B5860-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 282 EUR |
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes. |
|||
TAK960 |
|||
B5860-50 | ApexBio | 50 mg | 811.2 EUR |
Description: Description:IC50: 8.4 to 46.9 nmol/L for multiple cancer cell linesPolo-like kinase 1 (PLK1) is a serine/threonine protein kinase involved in key mitosis processes. |
|||
TAK-733 |
|||
2460-25 | Biovision | each | 966 EUR |
TAK-733 |
|||
2460-5 | Biovision | each | 288 EUR |
TAK-632 |
|||
2473-25 | Biovision | each | 692.4 EUR |
TAK-632 |
|||
2473-5 | Biovision | each | 222 EUR |
TAK-242 |
|||
A3850-10 | ApexBio | 10 mg | 309.6 EUR |
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1]. |
|||
TAK-242 |
|||
A3850-100 | ApexBio | 100 mg | 1730.4 EUR |
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1]. |
|||
TAK-242 |
|||
A3850-5 | ApexBio | 5 mg | 226.8 EUR |
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1]. |
|||
TAK-242 |
|||
A3850-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 243.6 EUR |
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1]. |
|||
TAK-242 |
|||
A3850-50 | ApexBio | 50 mg | 1034.4 EUR |
Description: IC50: With IC50 of 1.1 to 11 nM, TAK-242 inhibited LPS-induced NO production, tumor necrosis factor-alpha and interleukin (IL)-6 in RAW264.7 cells and mouse peritoneal macrophages [1]. |
|||
TAK-901 |
|||
A4124-10 | ApexBio | 10 mg | 324 EUR |
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention. |
|||
TAK-901 |
|||
A4124-200 | ApexBio | 200 mg | 2133.6 EUR |
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention. |
|||
TAK-901 |
|||
A4124-5 | ApexBio | 5 mg | 212.4 EUR |
Description: IC50: 0.0017, 0.021 for Aurora-B/INCENP and Aurora-A/TPX2, respectivelyProtein kinases Aurora A, B, and C play crucial roles during mitosis and cell division, are frequently elevated in cancer, and represent attractive targets for therapeutic intervention. |